FDA Approved: SPIRIVA RESPIMAT — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Spiriva Respimat (tiotropium bromide inhalation spray) from Boehringer Ingelheim as an original drug approval for chronic obstructive pulmonary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• SPIRIVA RESPIMAT (tiotropium bromide inhalation spray)

Snippet

ORIG AP for SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE INHALATION SPRAY)